Skip to content

A comparative study between oral midodrine and placebo for prevention of spinal anaesthesia induced hypotension in lower abdominal surgery.

Study of prophylactic role of oral midodrine on incidence of hypotension after subarachnoid block in lower abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039702
Enrollment
112
Registered
2022-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Oral midodrine on incidence of hypotension after subarachnoid block in lower abdominal surgery: Oral 5 mg tablet of midodrine with small sips of water one hour before subarachnoid block

Sponsors

Institute Medical Sciences Banaras Hindu University Varanasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patients belonging to American Society of Anaesthesiologists (ASA) classification I & II status.2-Patients undergoing for elective lower abdominal surgery.

Exclusion criteria

Exclusion criteria: 1- Patient refusal 2-Patient having contraindication of Midodrine:- (a)Pheochromocytoma (b) Hypersensitivity to drug (c) severe heart disease (d) Hyperthyroidism (e) Uncontrolled hypertension (f) Increased intracranial tension (g) acute renal disease (h) Hepatic impairment 3-Elderly population or pediatric population 4-During pregnancy and breast feeding 5-Patient having contraindication of subarachnoid block

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative Hypotension ( change in systolic blood pressure and diastolic blood pressure)Timepoint: Time from administration of drug or placebo to the end of surgery

Secondary

MeasureTime frame
1-change in Mean arterial blood pressure 2-Change in Heart Rate 3-Requirements of Mephentermine and Atropine 4-Incidence of adverse effects (time frame: up to 24 hours surgery)Timepoint: Before the administration of drug and intra-operative at every 3 minute interval for 15 minutes then at every 5 minute interval for 30 minutes then at every 10 minutes interval up to 60 minutes then at every 15 minutes till the end of surgery

Countries

India

Contacts

Public ContactDr S K Mathur

Institute of Medical sciences,Banaras Hindu University,Varanasi

skmathurbhu@gmail.com9450955143

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026